Health Care · Medicinal Chemicals & Botanical Products · OTC · CIK 1134765 · FYE Dec 31 · Prices AT CLOSE 2026-08-28 (USD) Last $0.24 · Day +8.99% · Mkt cap $62M · P/E (FY) 11.0× · 1Y −11.0% · Off 52W high −36.8% · Vol (1Y) 111.6% Price2023-08-28 → 2026-08-28 CHUC close: $0.08 on 2023-08-28 to $0.24 on 2026-08-28. Split-adj closes · 240 of 3,368 · price returnⓘ At a glance | Short interest0.0% of sh out | | Days to cover1.0d | | Top-10 13F concentration100.0% | | Next report (est.)2026-11-15 |
SI 2026-08-14 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)11.0× | | Sales (TTM)$26.2M | | Earnings (TTM)-$2.0M | | Net margin21.5% | | Sales growth 3Y−7.5% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−21.1% | | 1Y−11.0% | | 3Y+185.0% | | 5Y+0.0% | | 10Y+49.1% | | Since incept. (ann.)−18.2% |
Total return · from 2013-01-02ⓘ Risk | Ann. volatility (1Y)111.6% | | Ann. volatility (3Y)137.8% | | Sharpe (1Y)0.49 | | Sharpe (3Y)0.92 | | Max drawdown (1Y)−59.2% | | Max drawdown (3Y)−85.7% | | Beta (3Y vs SPY)0.17 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Ascentis Wealth Management, LLC | 923 | $263 | 0.00% | new | | RESOURCES MANAGEMENT CORP /CT/ /ADV | 200 | $0 | 0.00% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-17 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-17 | — | — | $3.8M | +115.9% | | 2026-03-31 | 2026-05-20 | — | — | $4.8M | +204.4% | | 2025-12-31 | 2026-04-01 | — | — | $10.5M | +902.2% | | 2025-09-30 | 2025-11-19 | $0.00 | — | $7.1M | +336.2% |
As-reported XBRL · next 2026-11-15 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
